2020•European Journal of CancerRequires access

Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years

Maartje van Seijen, Esther H. Lips, Liping Fu, Ewout J. N. Groen, Frederieke van Duijnhoven, A.M. Thompson, P. Elkhuizen, MK Schmidt, Jelle Wesseling, Michael Schaapveld

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ductal carcinoma, Medicine, In situ, Carcinoma in situ, Mastectomy, Breast cancer, Breast-conserving surgery, Radiation therapy

Back to paper search Browse research topics Original source

Risk of subsequent in situ and invasive lesions after a primary diagnosis of ductal carcinoma in situ with follow-up time up to 28 years — Research Paper | ScholarLens